(Q33223485)

24 July 2017

1 reference

title

Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits (English)

1 reference

24 July 2017

0 references

Picard C

1

1 reference

24 July 2017

Fioramonti J

2

1 reference

24 July 2017

Francois A

3

1 reference

24 July 2017

Robinson T

4

1 reference

24 July 2017

Neant F

5

1 reference

24 July 2017

Matuchansky C

6

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Alimentary Pharmacology & Therapeutics

24 July 2017

1 reference

24 July 2017

22

1 reference

24 July 2017

495-512

1 reference

24 July 2017

6

1 reference

Gut flora in health and disease

24 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Comparative study of bacterial groups within the human cecal and fecal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

In vivo safety assessment of two Bifidobacterium longum strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Safety of probiotics that contain lactobacilli or bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Phylogenetic analysis of the genus Bifidobacterium and related genera based on 16S rDNA sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Regulatory effects of bifidobacteria on the growth of other colonic bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Reduction of virus shedding by B. bifidum in experimentally induced MRV infection. Statistical application for ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Probiotics to enhance anti-infective defences in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Review article: antibiotics and probiotics in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Effects of dairy products on heterocyclic aromatic amine-induced rat colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Nitrates, nitrites and N-nitrosocompounds: a review of the occurrence in food and diet and the toxicological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Fermented milks, probiotic cultures, and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Increasing ursodeoxycholic acid in the enterohepatic circulation of pigs through the administration of living bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Bifidobacterium animalis strain DN-173 010 hydrolyses bile salts in the gastrointestinal tract of pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Antimutagenicity of components of dairy products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

New approach to phylogenetic analysis of the genus Bifidobacterium based on partial HSP60 gene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

Short fractions of oligofructose are preferentially metabolized by Bifidobacterium animalis DN-173 010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02615.X

10.1111/J.1365-2036.2005.02615.X

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference